Suppr超能文献

一项关于心脏和非心脏 1.5-T MRI 在传统起搏器或传统植入式心脏复律除颤器患者中的安全性和诊断价值的八年前瞻性对照研究。

An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.

机构信息

Arrhythmia and Electrophysiology Centre, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Humanitas Clinical Research Institute, Arrhythmia and Electrophysiology Unit II, Rozzano, Milan, Italy.

出版信息

Eur Radiol. 2018 Jun;28(6):2406-2416. doi: 10.1007/s00330-017-5098-z. Epub 2018 Jan 9.

Abstract

OBJECTIVES

To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD).

METHODS

We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG).

RESULTS

142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three-12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic.

CONCLUSIONS

A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.

KEY POINTS

• Cooperation between radiologists and cardiac electrophysiologists allowed safe 1.5-T MRI in cPM/cICD-carriers. • No adverse events for 142 MRI in 71 cPM-carriers and 71 cICD-carriers. • Ninety-nine per cent (86/87) of non-cardiac MRI in cPM/cICD-carriers were diagnostic. • All cPM-carrier cardiac MRIs had artefacts, 14 examinations diagnostic, 1 partially diagnostic. • Twenty-three per cent (9/40) of cardiac MRI in cICD-carriers were non-diagnostic.

摘要

目的

研究 1.5T MRI 对传统起搏器(cPM)或传统植入式除颤器(cICD)携带者的安全性和诊断价值。

方法

我们前瞻性比较了接受 MRI(研究组,SG)的 cPM/cICD 携带者,排除了设备依赖或植入 <6 周前或 2000 年 1 月 1 日前的携带者,以及接受胸部 X 线、CT 或随访的 cPM/cICD 携带者(对照组,RG)。

结果

在 120 例接受 cPM(n=71)或 cICD(n=71)的患者中进行了 142 次 MRI(55 次心脏)。在 RG 中,95 例接受 cPM(n=40)或 cICD(n=58)的患者进行了 98 次测量。未观察到不良事件。没有 MRI 延长/中断。所有 cPM/cICD 在 MRI 后均正确重新编程,无故障。在 1 例 cPM 携带者中观察到 1 次临时通讯故障。MRI 后立即,12/14 个设备检测参数无明显变化(电池电压和 cICD 充电时间的临床可忽略变化),SG 与 RG 之间无显著差异。MRI 后 3-12 个月,9/11 个设备检测参数无明显变化(电池阻抗/电压的临床可忽略变化)。心肌坏死的三个标志物无明显变化。非心脏 MRI:82/87 次无伪影诊断;4/87 次有伪影诊断;1/87 次部分诊断。心脏 MRI:在 cPM 携带者中,14/15 次有伪影诊断,1/15 次部分诊断;在 cICD 携带者中,9/40 次有伪影诊断,22 次部分诊断,9 次非诊断。

结论

报告了 1.5T MRI 在 cPM/cICD 携带者中的有利风险效益比。

关键点

  • 放射科医生和心脏电生理学家之间的合作允许对 cPM/cICD 携带者进行安全的 1.5T MRI。

  • 在 71 例 cPM 携带者和 71 例 cICD 携带者中,142 次 MRI 无不良事件。

  • 99%(86/87)的 cPM/cICD 携带者的非心脏 MRI 可诊断。

  • 所有 cPM 携带者的心脏 MRI 均有伪影,14 次检查可诊断,1 次部分诊断。

  • cICD 携带者中有 23%(9/40)的心脏 MRI 不可诊断。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验